Katie Peng
Director/Board Member at SCHOLAR ROCK HOLDING CORPORATION
Net worth: 374 477 $ as of 2024-04-29
Profile
Katie Peng is currently an Independent Director at Scholar Rock Holding Corp., a Director at California Life Sciences Association, an Independent Director at Adicet Bio, Inc., and the Chief Commercial Officer at Denali Therapeutics, Inc. She previously worked as the Senior Vice President & Head-OMNI Business Unit at Genentech, Inc. Ms. Peng completed her undergraduate degree at the University of California, Berkeley and holds an MBA from Kelley School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-08 | 26,825 ( 0.03% ) | 374 477 $ | 2024-04-29 | |
ADICET BIO INC
-.--% | 2024-04-08 | 0 ( -.--% ) | - $ | 2024-04-29 |
Katie Peng active positions
| Companies | Position | Start |
|---|---|---|
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 2021-09-26 |
| ADICET BIO, INC. | Director/Board Member | 2023-07-09 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 2024-02-14 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | - |
Former positions of Katie Peng
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Katie Peng
| University of California, Berkeley | Undergraduate Degree |
| Kelley School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| ADICET BIO, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
- Stock Market
- Insiders
- Katie Peng
